Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Intimation Of Book Closure

 Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the Register of Members and Share Transfer Books of the Company will remain closed from 22nd July, 2019 to 29th July, 2019 (both days inclusive) for taking record of the Members of the Company for the purpose of payment of Dividend and Annual General Meeting of the Company for the F.Y. 2018-19. Symbol Type of security Book Closure (Both days inclusive) Record Date Purpose From To APLLTD Equity 22nd July, 2019 29th July, 2019 N.A. Payment of Dividend and Annual General Meeting of the Company for the F.Y. 2018-19 We request you to kindly take the same on your record and display the same on the website of the Stock Exchange.
10-06-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Submission Of Notice Of 9Th Annual General Meeting Of The Company

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Notice of 9th Annual General Meeting of the Members of the Company scheduled to be held on Monday, the 29th July, 2019 at 3:00 p.m. at 'Sanskruti', Alembic Corporate Conference Center, Opp. Pragati Sahakari Bank Limited, Alembic Colony, Vadodara - 390 003. We request you to kindly take the same on record.
10-06-2019
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Reg. 34 (1) Annual Report

 Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of the Annual Report of the Company for the financial year ended 31st March, 2019. We request you to kindly take the same on record.
10-06-2019
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Board Meeting Intimation for Board Meeting To Consider The Proposal For Issue Of Non-Convertible Debentures On Private Placement Basis.

 ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2019 ,inter alia, to consider and approve the proposal for issue of Non-Convertible Debentures on Private Placement Basis.
06-06-2019
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Carbidopa and Levodopa Extended-Release Tablets USP, 25 mg/100 mg and 50 mg/200 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.
06-06-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of advertisement related to notice of loss of share certificates published by the Company on behalf of the shareholder(s) and / or legal heir(s) of the registered shareholder(s) in English language newspaper - Business Standard on 31st May, 2019.
31-05-2019
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the Company has issued Duplicate Share Certificate(s) to the registered shareholder(s) on 30th May, 2019.
30-05-2019
Bigul

Alembic Pharmaceuticals Ltd - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the share certificate(s) of the Company has been reported as lost/misplaced and the shareholder(s) of such lost share certificate(s) have requested the Company for issue of duplicate share certificate(s).
30-05-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015 ('Listing Regulations, 2015')

 Pursuant to Regulation 23(9) of the Listing Regulations, 2015, we enclose herewith Disclosure of Related Party Transactions, on a consolidated basis, for the period ended 31st March, 2019. We request you to kindly take the same on record.
24-05-2019
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations, 2015')

 Pursuant to Regulation 30 of the Listing Regulations, 2015, we enclose herewith a specimen of the reminder letter dated 20th May, 2019 sent to the relevant shareholders for whom the dividend remains unpaid / unclaimed for seven or more consecutive years and whose shares are liable to be transferred to the Investor Education and Protection Fund ('IEPF') Authority as per Section 124(6) of the Companies Act, 2013 read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from time to time. We request you to kindly take the same on record.
24-05-2019
Next Page
Close

Let's Open Free Demat Account